Human Leukocyte Antigen Testing Market Forecast and Growth Drivers (2026-2034)
Coverage: Human Leukocyte Antigen (HLA) Testing Market covers analysis By Product and Services (Reagents & Consumables, Instruments, and Software & Services), Technology [Molecular Assay Technologies (PCR-Based Molecular Assays, Sequencing-Based Molecular Assays, and Others) and Non-Molecular Assay Technologies], and End User (Independent Reference Laboratories, Hospitals and Transplant Centers, and Others), and Geography
- Report Date : Feb 2026
- Report Code : TIPRE00021578
- Category : Life Sciences
- Status : Upcoming
- Available Report Formats :
- No. of Pages : 150
The Human Leukocyte Antigen Testing market size is expected to reach US$1,780.10 million by 2034 from US$930.91 million in 2025. The market is anticipated to register a CAGR of 7.47% during the forecast period from 2026–2034.
Human Leukocyte Antigen Testing Market AnalysisThe Human Leukocyte Antigen Testing market forecast indicates robust growth, primarily driven by the escalating demand for accurate immune compatibility assessment in transplantation, the shift toward high-resolution molecular methods like Next-Generation Sequencing (NGS), and the increasing application of HLA typing in diagnosing autoimmune diseases and predicting drug hypersensitivity (pharmacogenomics). The market expansion is significantly facilitated by the continuous integration of automation and bioinformatics software, which improves throughput and data management in testing laboratories globally.
Human Leukocyte Antigen Testing Market OverviewHLA testing is a critical diagnostic procedure that determines the compatibility between a donor and a recipient for organ, tissue, and hematopoietic stem-cell transplantation. HLA proteins, located on the surface of most cells, are responsible for regulating the immune system, and their accurate matching is essential to minimize the risk of transplant rejection (graft-versus-host disease) and improve long-term graft survival. Beyond transplantation, HLA testing is gaining traction in diagnostics, particularly for celiac disease, rheumatoid arthritis, and other immune-mediated disorders, as well as in pharmacogenomics to assess patient response to specific medications. The market structure is heavily skewed towards Reagents and Consumables, which account for over 70% of total revenue due to the repetitive nature of testing and the high throughput volumes in reference laboratories and transplant centers.
Strategic Insights
Human Leukocyte Antigen Testing Market Drivers and OpportunitiesMarket Drivers:
- Adoption of High-Resolution Molecular Diagnostics: The strategic shift from low-resolution serological methods to high-resolution molecular techniques, especially NGS, is driving market value. NGS offers superior specificity, faster turnaround times, and the ability to detect novel alleles, making it the gold standard for compatibility testing.
- Expansion of HLA Testing in Autoimmune and Chronic Diseases: Growing clinical evidence linking specific HLA alleles to autoimmune conditions (like Type 1 diabetes and ankylosing spondylitis) is increasing the utilization of HLA typing for diagnostic confirmation and risk stratification.
- Increasing Applications in Pharmacogenomics: HLA testing is crucial for predicting adverse drug reactions (e.g., drug hypersensitivity syndrome associated with certain HIV or anti-epileptic drugs), thereby expanding its scope beyond the traditional transplant setting.
Market Opportunities:
- Expansion in Emerging Markets: Developing regions, particularly in Asia-Pacific (China, India) and South & Central America, offer significant untapped potential. Rising healthcare infrastructure, increased public and private investment in diagnostic capabilities, and a growing pool of transplant candidates are fueling the rapid adoption of molecular platforms.
- Integration with Automation and Artificial Intelligence (AI): The demand for AI-driven data analytics and automated laboratory workflows is creating opportunities to develop integrated software solutions that can quickly interpret complex HLA data, reduce human error, and streamline reporting for clinicians.
- Development of Single-Cell HLA Transcript Analysis: Emerging technologies focusing on single-cell analysis for HLA transcription promise enhanced allele specificity in complex, mixed-sample analysis, offering new avenues for precision diagnostics.
The HLA testing market share is analyzed across various segments to provide a clearer understanding of its structure, technological landscape, and end-user adoption patterns. Below is the standard segmentation approach used in most industry reports:
By Product & Services:
- Reagents & Consumables
- Instruments
- Software & Services
By Technology:
- Molecular Assay Technologies
- Non-Molecular Assay Technologies
By End User:
- Independent Reference Laboratories
- Hospitals & Transplant Centers
By Geography:
- North America
- Europe
- Asia Pacific
- South & Central America
- Middle East & Africa
Market Report Scope
Human Leukocyte Antigen Testing Market Share Analysis by GeographyThe market displays a varied growth trajectory across regions, influenced by healthcare spending, regulatory environments, and transplantation volumes. Below is a summary of market share and trends by region:
-
North America
- Market Share: Holds the largest market share due to high transplant procedure volumes, early and mandatory adoption of advanced molecular assays (NGS), and well-established diagnostic reimbursement policies.
- Key Drivers: High prevalence of chronic diseases necessitating organ transplants; strong presence of key market players; advanced healthcare infrastructure.
- Trends: Continuous integration of NGS-based typing and sophisticated bioinformatics platforms for data interpretation and management.
-
Europe
- Market Share: Holds a significant share, driven by mature public healthcare systems and a high rate of stem-cell and solid organ transplantation across major countries (Germany, UK, France).
- Key Drivers: Strict regulatory standards requiring high-resolution typing; national/regional transplant registries driving testing standardization.
- Trends: Increasing focus on quality assurance and external quality assessment schemes (EQAS) to standardize HLA typing results across the continent.
-
Asia Pacific
- Market Share: Expected to witness the fastest growth during the forecast period.
- Key Drivers: Rapid digitalization and modernization of healthcare facilities; government support for organ donation and transplant programs in countries like China and India; increasing awareness of the HLA role in disease diagnostics.
- Trends: Rapid adoption of PCR and NGS platforms, moving away from older serological methods, fueled by rising healthcare expenditure and medical tourism.
-
South & Central America / Middle East & Africa
- Market Share: Emerging markets with developing but significant growth potential.
- Key Drivers: Increasing healthcare investments, expansion of private clinics and specialist transplant centers, and public-private partnerships aiming to improve infrastructure.
- Trends: Introduction of cost-effective, automated instruments and standardized reagent kits to manage increasing testing volumes efficiently.
Competition is intense, characterized by companies offering integrated solutions, combining reagents, instruments, and software. Key vendors focus on innovation in molecular diagnostics, particularly NGS-based kits, to achieve higher resolution and faster results.
Major Companies Operating in the HLA Testing Market:- Thermo Fisher Scientific Inc.
- CareDx
- Qiagen
- Illumina Inc.
- Bio-Rad Laboratories, Inc.
- TBG Diagnostics Limited
- F. Hoffmann-La Roche Ltd.
- Takara Bio Inc.
- Luminex Corporation
Disclaimer: The companies listed above are not ranked in any particular order.
Human Leukocyte Antigen Testing Market News and Recent Developments- Qiagen showcases automation in HLA typing workflows using the QIAxcel capillary electrophoresis system combined with Olerup SSP kits.
- Qiagen also offers the QIAseq xHYB Long Read HLA Typing Panel, enabling full-length, high-resolution sequencing of HLA class I & II alleles using long-read technologies such as PacBio and Oxford Nanopore.
- Illumina Inc. promotes NGS-based HLA typing solutions with ultra-high-resolution typing using SBS chemistry and phased paired-end reads.
- Illumina supports the TruSight HLA v2 Sequencing Panel, featuring enhanced software that improves structural variant detection by ~30%. The company also announced DRAGEN v4.4 pipeline support, enabling two-field resolution HLA genotyping for loci such as HLA-A, -B, and -C.
- F. Hoffmann-La Roche Ltd. offers the LightMix Kit for HLA-B27 detection using PCR melt-curve analysis on LightCycler instruments.
- Roche also highlights its NGS-based immunogenetics applications, which include support for HLA typing as part of broader sequencing solutions.
The "Human Leukocyte Antigen Testing Market Size and Forecast (2021–2034)" report provides a detailed analysis of the market covering below areas:
- Human Leukocyte Antigen Testing Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope.
- Human Leukocyte Antigen Testing Market trends, as well as market dynamics such as drivers, restraints, and key opportunities.
- Detailed competitive analysis covering market concentration, heat map analysis, prominent players, and recent developments.
- In-depth PEST and SWOT analysis of the market environment.
- Detailed company profiles and competitive landscape.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product and Services, Technology, and End User, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Key players in the Human Leukocyte Antigen Testing Market include Thermo Fisher Scientific, CareDx, Qiagen, Illumina, and Bio-Rad, supported by continued innovation in NGS panels, automation platforms, and integrated software solutions.
North America will dominate the Human Leukocyte Antigen Testing Market due to high transplant volumes and strong molecular diagnostics adoption, while Asia-Pacific will experience the fastest growth as healthcare modernization accelerates.
The Human Leukocyte Antigen Testing Market is being shaped by NGS-based high-resolution typing, PCR-based molecular assays, automation systems, and advanced bioinformatics tools that streamline data interpretation.
The Human Leukocyte Antigen Testing Market is expected to grow from US$930.91 million in 2025 to US$1,780.10 million by 2034, supported by a 7.47% CAGR driven by technological advancements and broader clinical adoption.
Growth in the Human Leukocyte Antigen Testing Market is driven by rising transplant procedure volumes, increasing use of high-resolution molecular methods such as NGS, and expanding applications in autoimmune disease diagnostics and pharmacogenomics.
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For